2015
DOI: 10.1136/annrheumdis-2015-eular.4572
|View full text |Cite
|
Sign up to set email alerts
|

AB0491 Current Management Patterns of Synthetic Dmards for Rheumatoid Arthritis in the Clinical Practice Setting: Sar-Fame Study: Table 1.

Abstract: BackgroundThe application of the “treat-to-target” strategy in rheumatoid arthritis requires being proactive in the management of the disease to get the better outcomes. The treatment changes in daily practice are directed to improve the efficacy and/or tolerance, and also reduce the toxicity.ObjectivesThe present study aimed to describe the percentage of patients who suffered a change in their synthetic DMARD regimen due to loss of efficacy (LoE), adverse events (AEs), intolerance, and other reasons. Also the… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles